宏细胞迁移抑制因子小分子抑制剂的发展进展
Shujin Guo1, Yingying Zhao2, Yan Yuan3
1Department of Health Management Center, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
European journal of medicinal chemistry
|January 24, 2025
概括
巨细胞迁移抑制因子 (MIF) 是炎症和免疫的关键细胞因子,与癌症和自身免疫性疾病有关. 这一审查详细介绍了MIF的细节.
科学领域:
- 免疫学和分子生物学
- 药用化学 医学化学
- 病变发生学研究 病变发生学研究
背景情况:
- 巨细胞迁移抑制因子 (MIF) 是一种调节炎症和免疫反应的关键细胞因子.
- MIF与癌症,自身免疫性疾病和炎症性疾病的发病有关,使其成为治疗点.
- 目前的治疗策略侧重于使用小分子和天然化合物抑制MIF活性.
研究的目的:
- 综合有关MIF的当前知识,包括其结构,功能,信号和疾病作用.
- 提供对MIF抑制剂开发近期进展的深入分析.
- 支持创建更安全,更有效和选择性的MIF向小分子抑制剂.
主要方法:
- 文献综述和对MIF现有研究的综合.
- 对MIF抑制剂设计方法和结构-活性关系的分析.
- 检查先进的体分析技术和MIF抑制中的实验发现.
主要成果:
- 该审查涵盖了MIF的结构和酶功能,信号通路和疾病参与.
- 分析了小分子抑制剂开发的最新进展,包括设计策略和SAR.
- 讨论了MIF抑制剂的先进分析技术和实验结果.
结论:
- MIF是抗炎和抗癌疗法的重要目标.
- 对MIF抑制剂设计和开发的持续研究对于治疗进步至关重要.
- 综合知识的目的是指导新型选择性MIF抑制剂的开发.
相关概念视频
Negative Regulator Molecules
32.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Cell Migration
16.6K
Cell migration, the process by which cells move from one location to another, is essential for the proper development and viability of organisms throughout their life. When cells are not able to migrate properly to their ordained locations, various disorders may occur. For example, disruption in cell migration causes chronic inflammatory diseases such as arthritis.
16.6K


